Need help? Text us, and a team member will reply help@aminosociety.org Need help? Text us, and a team member will reply help@aminosociety.org Need help? Text us, and a team member will reply help@aminosociety.org

In Stock

≥99% Purity · HPLC verified

Research Use Only

Tesamorelin Pen

Tesamorelin is a synthetic 44-amino-acid GHRH analog supplied as a lyophilized peptide for research use. Produced under controlled conditions. Investigated in GHRH receptor signaling, visceral adipose research, and lipid-metabolism pathway modeling.
Select Size or Weight
1 VIAL
2 VIALS Save 5%
3+ VIALS Save 10%
≥99% Purity

HPLC verified

Lab tested

HPLC + MS

Same-day ship

Order by 2pm
PT

  • FREE shipping on orders over $200
  • Same-day dispatch if ordered before 2pm EST (Mon-Fri)
  • Estimated delivery: 2-3 business days via USPS Priority Mail
CERTIFICATE OF ANALYSIS THIRD-PARTY VERIFIED BY HPLC & MASS SPECTROMETRY
VIEW COA
Products

Recommended Research Stacks Research Stacks Research Stacks

Amino Society Pen

Retatrutide Pen

Amino Society Pen

MOTC Pen

Wolverine Pen

$20.00

GLOW Pen

$50.00
Amino Society PENS

PENS

$20.00
Identity

Compound Information Information Information

Tesamorelin Pen Overview

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH), modified for enhanced stability against enzymatic degradation. It is studied for its interaction with pituitary GHRH receptors and pulsatile growth hormone release.
CAS Number
218949-48-5
Molecular Formula
C221H366N72O67S
Molecular Weight
5135.86 g/mol
Composition
44-amino-acid synthetic GHRH(1-44) analog
Half-Life
Short; approximately 25-30 minutes in circulating research models
Source
Synthetic (solid-phase peptide synthesis)
Purity
99.0% (HPLC Verified)
Form
Dual-cartridge pen (lyophilized compound + diluent in sealed cartridges, combined at time of use)
Solubility
Highly soluble in water, bacteriostatic water

History

Tesamorelin was developed as a stabilized GHRH analog and has been the subject of extensive published clinical and preclinical research into growth hormone axis regulation, including approved research into HIV-associated lipodystrophy models.

Stability Information

Long-term

−20°C

Lyophilized powder, sealed

Reconstituted

2–8°C

Up to 30 days when refrigerated

Shipping

Room temp

Stable in transit, lyophilized

Protection

Light · Moisture

Store sealed, away from light

Research Findings

Tesamorelin has been studied in laboratory, animal, and clinical research models of GHRH receptor signaling, visceral fat metabolism, and pituitary growth hormone secretion pathways.

Key Areas of Research:

Endocrine
GHRH receptor signaling, pituitary axis research
Metabolic
Visceral fat and lipid metabolism studies
Clinical Research
Extensively documented in published literature

Together, these findings support Tesamorelin's role as one of the most well-characterized GHRH analogs in growth hormone axis research.

Important Safety Information

All products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption, ingestion, injection, inhalation, application to the skin, or any other clinical use. Not approved by the FDA for any therapeutic purpose. Intended exclusively for qualified researchers in a controlled laboratory environment. By purchasing, you acknowledge and agree to use this material in compliance with all applicable laws and your institutional protocols.